Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Małgorzata Firczuk, Angelika Muchowicz et al.|Oncogene|2022Cited by 18
Abstract 3324: Optimizing the therapeutic potential of tyrosine kinase inhibitors in chemo-immunotherapy of B-cell acute lymphoblastic leukemia involving rituximabKrzysztof Domka, Małgorzata Firczuk, Martyna Poprzeczko et al.|Cancer Research|2022Cited by 1
P339: BOOSTING THE EFFICACY OF CD20-TARGETING IMMUNOTHERAPY IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIAMartyna Poprzeczko, Małgorzata Firczuk, Krzysztof Domka et al.|HemaSphere|2022Cited by 0